Form 4: USANA Health Sciences CFO Doug Iiekkings Reports Stock Transactions

Chief Financial Officer Doug Iiekkings of USANA Health Sciences Inc. reports transactions involving common stock and restricted stock units.

Summary

• Doug Iiekkings, CFO of USANA Health Sciences Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 6, 2025, Iiekkings exercised 3,533 restricted stock units and disposed of 2,027 shares of common stock at a price of $31.21.
• Following these transactions, Iiekkings directly owns 1,506 shares of common stock.
• On February 7, 2025, Iiekkings exercised 2,232 restricted stock units and disposed of 1,281 shares of common stock at a price of $30.65.
• Following these transactions, Iiekkings directly owns 2,457 shares of common stock.
• Iiekkings also directly owns 30,188 and 27,956 restricted stock units after the transactions on February 6th and 7th respectively.
• The restricted stock units vest 25% on the anniversary of February 6, 2023, and February 7, 2022.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Comparing USANA's insider trading activity to similar companies in the nutritional supplement industry, such as Herbalife Nutrition and Nu Skin Enterprises, reveals that stock option exercises and sales are common practice for executive compensation.
• The vesting schedules and amounts of restricted stock units are generally aligned with industry standards for incentivizing long-term performance and aligning executive interests with shareholder value.
• The reported transactions are typical for executives managing their personal portfolios and do not necessarily indicate a change in the company's outlook.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
• The transactions are part of the executive's compensation and do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

USANA Health Sciences, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Iiekkings, CFO, USNA, Restricted Stock Units